Jaguar Animal Health (JAGX) Competitors $2.22 -0.01 (-0.45%) Closing price 08/6/2025 03:59 PM EasternExtended Trading$2.22 0.00 (0.00%) As of 08/6/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock JAGX vs. DWTX, KPRX, ADXN, GNPX, AEON, SNSE, TRAW, CHRO, TLPH, and NKGNShould you be buying Jaguar Animal Health stock or one of its competitors? The main competitors of Jaguar Animal Health include Dogwood Therapeutics (DWTX), Kiora Pharmaceuticals (KPRX), Addex Therapeutics (ADXN), Genprex (GNPX), AEON Biopharma (AEON), Sensei Biotherapeutics (SNSE), Traws Pharma (TRAW), Chromocell Therapeutics (CHRO), Talphera (TLPH), and NKGen Biotech (NKGN). These companies are all part of the "pharmaceutical products" industry. Jaguar Animal Health vs. Its Competitors Dogwood Therapeutics Kiora Pharmaceuticals Addex Therapeutics Genprex AEON Biopharma Sensei Biotherapeutics Traws Pharma Chromocell Therapeutics Talphera NKGen Biotech Dogwood Therapeutics (NASDAQ:DWTX) and Jaguar Animal Health (NASDAQ:JAGX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, valuation, earnings and dividends. Which has more volatility & risk, DWTX or JAGX? Dogwood Therapeutics has a beta of 1.8, meaning that its share price is 80% more volatile than the S&P 500. Comparatively, Jaguar Animal Health has a beta of 0.43, meaning that its share price is 57% less volatile than the S&P 500. Do institutionals & insiders have more ownership in DWTX or JAGX? 9.1% of Dogwood Therapeutics shares are held by institutional investors. Comparatively, 12.0% of Jaguar Animal Health shares are held by institutional investors. 3.9% of Dogwood Therapeutics shares are held by insiders. Comparatively, 4.6% of Jaguar Animal Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Is DWTX or JAGX more profitable? Dogwood Therapeutics has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -343.92%. Dogwood Therapeutics' return on equity of 0.00% beat Jaguar Animal Health's return on equity.Company Net Margins Return on Equity Return on Assets Dogwood TherapeuticsN/A N/A -34.74% Jaguar Animal Health -343.92%-432.91%-71.25% Do analysts rate DWTX or JAGX? Dogwood Therapeutics presently has a consensus target price of $10.00, suggesting a potential upside of 110.08%. Jaguar Animal Health has a consensus target price of $60.00, suggesting a potential upside of 2,602.70%. Given Jaguar Animal Health's higher probable upside, analysts clearly believe Jaguar Animal Health is more favorable than Dogwood Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dogwood Therapeutics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Jaguar Animal Health 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has higher valuation & earnings, DWTX or JAGX? Dogwood Therapeutics has higher earnings, but lower revenue than Jaguar Animal Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDogwood TherapeuticsN/AN/A-$12.35M-$18.04-0.26Jaguar Animal Health$11.55M0.37-$38.49MN/AN/A Does the media prefer DWTX or JAGX? In the previous week, Dogwood Therapeutics and Dogwood Therapeutics both had 1 articles in the media. Dogwood Therapeutics' average media sentiment score of 0.00 beat Jaguar Animal Health's score of -1.00 indicating that Dogwood Therapeutics is being referred to more favorably in the media. Company Overall Sentiment Dogwood Therapeutics Neutral Jaguar Animal Health Negative SummaryDogwood Therapeutics beats Jaguar Animal Health on 6 of the 10 factors compared between the two stocks. Get Jaguar Animal Health News Delivered to You Automatically Sign up to receive the latest news and ratings for JAGX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding JAGX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart JAGX vs. The Competition Export to ExcelMetricJaguar Animal HealthMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.27M$2.52B$5.57B$9.47BDividend YieldN/A1.78%4.31%4.13%P/E RatioN/A19.5129.3723.99Price / Sales0.37691.00444.1896.63Price / CashN/A162.3535.8458.51Price / Book0.185.208.085.58Net Income-$38.49M$31.61M$3.26B$265.35M7 Day Performance8.82%0.90%0.45%-0.07%1 Month Performance-12.60%6.97%4.83%1.76%1 Year Performance-91.70%6.15%30.28%25.39% Jaguar Animal Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)JAGXJaguar Animal Health1.8505 of 5 stars$2.22-0.4%$60.00+2,602.7%-92.3%$4.27M$11.55M0.0050Negative NewsUpcoming EarningsShort Interest ↑DWTXDogwood Therapeutics1.4572 of 5 stars$4.78+0.1%$10.00+109.4%N/A$9.12MN/A-0.265News CoveragePositive NewsGap UpKPRXKiora Pharmaceuticals2.724 of 5 stars$2.93-2.0%$10.00+241.3%-33.8%$9.10M$16.02M-1.0110News CoverageUpcoming EarningsADXNAddex Therapeutics2.9 of 5 stars$8.34-2.7%$30.00+259.7%+2.0%$9.08M$170.62K-24.5330Positive NewsGNPXGenprex1.3231 of 5 stars$0.26-3.7%N/A-84.4%$9.03MN/A0.0020News CoverageUpcoming EarningsGap DownAEONAEON Biopharma3.2372 of 5 stars$0.79-0.1%$360.00+45,527.4%-98.9%$8.92MN/A4.385Upcoming EarningsGap UpSNSESensei Biotherapeutics4.7207 of 5 stars$7.00+0.3%$90.00+1,185.7%-40.4%$8.80MN/A-0.3040News CoverageEarnings ReportAnalyst ForecastTRAWTraws PharmaN/A$1.62+2.5%N/AN/A$8.79M$230K-0.0517Positive NewsCHROChromocell TherapeuticsN/A$1.34+6.3%N/A-81.2%$8.69MN/A-1.084Gap UpHigh Trading VolumeTLPHTalphera2.1928 of 5 stars$0.43+2.1%$5.00+1,057.9%-54.2%$8.68M$650K-0.9619Positive NewsUpcoming EarningsShort Interest ↑Gap UpNKGNNKGen Biotech0.475 of 5 stars$0.19flatN/A-82.5%$8.54MN/A-0.04N/AShort Interest ↑ Related Companies and Tools Related Companies DWTX Alternatives KPRX Alternatives ADXN Alternatives GNPX Alternatives AEON Alternatives SNSE Alternatives TRAW Alternatives CHRO Alternatives TLPH Alternatives NKGN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:JAGX) was last updated on 8/7/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jaguar Animal Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Jaguar Animal Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free JAGX Stock Alerts